PROCID - Biosensor platform for rapid point-of-collection diagnosis of infectious diseases

PROCID计划旨在证明在低成本抗体生物传感器中使用印刷铜具有成本效益，用于疾病检测，最初针对STD的衣原体和淋病。这将使检测的方便性发生改变，以抗击和克服感染的传播。主要目标包括：开发基于固定化抗体的低成本生物传感器，定制生物传感器系统以快速检测目标生物(衣原体和淋病)，以及开发基于印刷的制造工艺，用于大规模生产生物传感器。总体目标是成功集成和交付一个功能原型系统，该系统提供一个低成本的基于传感器的传染病快速检测平台，具有真正的工业合作伙伴商业化潜力，并通过这样做降低NHS成本，提高检测率，帮助对抗重大健康危害，并促进远程医疗的实施。该财团由杰出的专家合作伙伴组成，包括利兹大学、Elisha Systems Ltd、Ryedale Group、Needham Group、Amies Innovation和P1 Technology，Intrinsiq材料公司领导该项目，并提供他们的新型铜墨和烧结技术。

The PROCID programme is designed to prove the cost effective use of printed copper in low cost antibody based biosensors for disease detection, initially targeting the STD’s Chlamydia and Gonorrhea. This will provide a step change in ease of detection to combat and overcome the spread of infections. Key objectives include: development of low-cost biosensors based around immobilised antibodies, tailoring the biosensing system to rapidly detect the target organisms (Chlamydia and Gonorrhea) and development of a printing-based fabrication process for mass-manufacturing of the biosensors. The overall aim is to successfully integrate and deliver a functional prototype system that provides a low-cost sensor-based platform for rapid detection of infectious disease, with real potential for commercialisation by the industrial partners, and in doing so reduce NHS costs, increase detection rates, help combat major health hazards, and facilitate the implementation of tele-healthcare. The consortium consists of distinguished specialist partners – Leeds University, ELISHA Systems Ltd, The Ryedale Group, The Needham Group, Amies Innovation and P1 Technology, with Intrinsiq Materials leading the programme and providing their novel copper ink and sintering technology.